- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
Patent holdings for IPC class A61P 1/00
Total number of patents in this class: 6875
10-year publication summary
|
250
|
239
|
420
|
481
|
571
|
640
|
667
|
714
|
504
|
208
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Société des Produits Nestlé S.A. | 9160 |
68 |
| Takeda Pharmaceutical Company Limited | 2703 |
53 |
| Novartis AG | 10975 |
43 |
| DSM IP Assets B.V. | 5672 |
38 |
| Nestec S.A. | 2682 |
37 |
| The Regents of the University of California | 19780 |
36 |
| N.V. Nutricia | 1053 |
33 |
| F. Hoffmann-La Roche AG | 7908 |
32 |
| AstraZeneca AB | 2933 |
32 |
| Cedars-Sinai Medical Center | 1135 |
32 |
| Janssen Pharmaceutica N.V. | 3437 |
31 |
| The Johns Hopkins University | 5626 |
30 |
| Glycom A/S | 251 |
30 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3357 |
28 |
| Raqualia Pharma Inc. | 122 |
27 |
| Ajinomoto Co., Inc. | 2300 |
25 |
| Astellas Pharma Inc. | 1082 |
25 |
| Boehringer Ingelheim International GmbH | 4705 |
24 |
| Eli Lilly and Company | 3795 |
24 |
| Taisho Pharmaceutical Co., Ltd. | 854 |
23 |
| Other owners | 6204 |